Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia.

Gardoni F, Morari M, Kulisevsky J, Brugnoli A, Novello S, Pisanò CA, Caccia C, Mellone M, Melloni E, Padoani G, Sosti V, Vailati S, Keywood C.

J Pharmacol Exp Ther. 2018 Dec;367(3):442-451. doi: 10.1124/jpet.118.251645. Epub 2018 Oct 5.

PMID:
30291173
2.

Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia.

García-Bonilla L, Sosti V, Campos M, Penalba A, Boada C, Sumalla M, Hernández-Guillamon M, Rosell A, Montaner J.

Brain Res. 2011 Feb 10;1373:211-20. doi: 10.1016/j.brainres.2010.12.005. Epub 2010 Dec 10.

PMID:
21146508
3.

Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.

Hernandez-Guillamon M, Garcia-Bonilla L, Solé M, Sosti V, Parés M, Campos M, Ortega-Aznar A, Domínguez C, Rubiera M, Ribó M, Quintana M, Molina CA, Alvarez-Sabín J, Rosell A, Unzeta M, Montaner J.

Stroke. 2010 Jul;41(7):1528-35. doi: 10.1161/STROKEAHA.110.584623. Epub 2010 Jun 10.

PMID:
20538694
4.

Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats.

Pérez V, Sosti V, Rubio A, Barbanoj M, Gich I, Rodríguez-Alvarez J, Kulisevsky J.

J Neural Transm (Vienna). 2009 Jul;116(7):867-74. doi: 10.1007/s00702-009-0242-9. Epub 2009 May 26.

PMID:
19468817
5.

Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.

Pérez V, Sosti V, Rubio A, Barbanoj M, Rodríguez-Alvarez J, Kulisevsky J.

Eur J Pharmacol. 2007 Dec 8;576(1-3):83-90. Epub 2007 Aug 25.

PMID:
17888901

Supplemental Content

Support Center